China is a highly attractive clinical trial destination, and continues to see increased interest from CROs and drug development companies. China has a well-established tradition of developing medicines from basic research and the demands for modern pharmaceuticals is growing. Data gathered from clinicaltrials.gov indicated that in 2014, China had conducted 846 clinical trials, and an […]
Read More
Chronic obstructive pulmonary disorder (COPD) is now the third most frequent cause of death in the world; however the cause of this disease for a substantial proportion of patients remains unknown.
Read More
George Clinical in China would like to wish all of our clients, sponsors and investigators the best wishes for Lunar New Year.
Read More
A diabetes epidemic is upon us, despite improved knowledge and therapy on this disease. The recently published 6th edition of the International Diabetes Federation Atlas provides some alarming figures.
Read More
In order to meet the growing needs of our customers, George Clinical has expanded its geographical footprint within Asia. In 2012 we saw the opening of a second George Clinical office in India in Bengaluru to complement our head office in Hyderabad. With many of our large outcomes studies recruiting patients in India there is […]
Read More
George Clinical China has appointed a new General Manager to lead its growing operation in China as it seeks to provide a stronger platform for delivering clinical trials across the Asian region. A recognised healthcare professional, Philip Gregory has 25 years senior management experience in pharmaceutical, device and biotechnology industries. Prior to taking up the […]
Read More
